Peptide RX

back to claim graph

proof receipt / finding

Initial digest — AGRP

AlphaFold v6 prediction landed for **AGRP** (Agouti-related protein). UniProt accession: `O00253`. Lane: `metabolic`. Mean per-residue pLDDT: **69.53**. Endogenous MC4R inverse agonist; PPI design target.

grade C status literature receipt 5f734fe46ee3 proof 33%

what this node claims

Initial digest — AGRP

AlphaFold v6 prediction landed for **AGRP** (Agouti-related protein). UniProt accession: `O00253`. Lane: `metabolic`. Mean per-residue pLDDT: **69.53**. Endogenous MC4R inverse agonist; PPI design target.

evidence / risk instrument

38%
thin proof
structure evidence gates risk export lineage 38
low debt pressure 32%
28%structuredebt
pLDDT pending
55%evidencethin
grade C
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine

proof completeness

33% missing target, alphafold_metric, candidate, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

confidence
0.6
evidence refs
1

AlphaFold metrics visual

Low-confidence regions present

69.5

132 residues / min 35.16 / max 96.06 / source alphafold db

PAE matrix for linked target
Very high 21.2% 28 residues / >=90
Confident 29.5% 39 residues / 70-89
Low 27.3% 36 residues / 50-69
Very low 22.0% 29 residues / <50

weak structural context; downstream claims should be conservative

Near-complete coverage / observed 132 of 132 residues.

  • residues 16-58 / mean 47.61
  • residues 75-85 / mean 60.44
  • residues 123-132 / mean 61.68
  • residues 1-1 / mean 65.25
proof debt register

Visible limits, not hidden cleanup.

32%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

high low evidence grade attach graded finding with source-linked evidence
low computational-only status add independent evidence, challenge result, or witness review before strengthening
low low-confidence AlphaFold regions likely attach pLDDT series, PAE matrix, or coverage evidence
medium no candidate yet leave visible until a stronger public receipt resolves it

weakness and challenge edges

What would stop this from becoming stronger.

debt severity export claim strength next proof needed
low evidence grade high blocks weakens attach graded finding with source-linked evidence
computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
low-confidence AlphaFold regions likely low visible watch attach pLDDT series, PAE matrix, or coverage evidence
no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it

what supports it

evidence finding attached fold:46338df4-b8aa-490b-998d-19932ee18178 -> finding:e161610a-0dfb-4a74-b0bd-7a1362733782 supports / C / 0.6

what it supports

No downstream proof edge yet.

Research-use boundary

This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.